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ABSTRACT
Background and Objectives: Decreased left atrial appendage (LAA) emptying velocity in 
transesophageal echocardiography (TEE) is related with higher incidence of thrombus and 
increased risk of stroke. Patients with valve disease are at higher risk of thrombus formation 
before and after surgery. The aim of this study was to investigate the role of 4-dimensional 
cardiac computed tomography (4DCT) to predict the risk of thrombus formation.
Methods: Between March 2010 to March 2015, total of 62 patients (mean 60±15 years old, 
male: 53.2%) who underwent 4DCT and TEE for cardiac valve evaluation before surgery 
were retrospectively included in the current study. Fractional area change in TEE view and 
emptying velocity at left atrial appendage in TEE view (VeTEE) were measured. Ejection 
fraction (EF) of left atrial appendage in computed tomography (EFCT) was calculated by 4DCT 
with full volume analysis. The best cut-off value of EFCT predicting presence of spontaneous 
echo contrast (SEC) or thrombus was evaluated, and correlation between the parameters 
were also estimated.
Results: SEC or thrombus was observed in 45.2%. EFCT and VeTEE were significantly correlated 
(r=0.452, p<0.001). However, fractional area change measured by TEE showed no correlation 
with VeTEE (r=0.085, p=0.512). EFCT <37.5% best predicted SEC or thrombus in the patients 
with valve disease who underwent 4DCT and TEE (area under the curve, 0.654; p=0.038).
Conclusions: In the patients who underwent 4DCT for cardiac valve evaluation before 
surgery, EFCT by volume analysis might have additional role to evaluate LAA function and 
estimate the risk of thrombus.
Keywords: Computed tomography; Atrial appendage; Thrombus
Korean Circ J. 2019 Feb;49(2):173-180
https://doi.org/10.4070/kcj.2018.0152
pISSN 1738-5520·eISSN 1738-5555
Original Article
Received: May 7, 2018
Revised: Aug 26, 2018
Accepted: Sep 18, 2018
Correspondence to
Hyuk-Jae Chang, MD, PhD
Division of Cardiology, Severance 
Cardiovascular Hospital, Yonsei University 
College of Medicine, Yonsei University Health 
System, 50-1, Yonsei-ro, Seodaemun-gu,  
Seoul 03722, Korea.
E-mail: HJCHANG@yuhs.ac
Copyright © 2019. The Korean Society of 
Cardiology
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted noncommercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
In-Cheol Kim 
https://orcid.org/0000-0002-5751-2328
Hyuk-Jae Chang 
https://orcid.org/0000-0002-6139-7545
Chi Young Shim 
https://orcid.org/0000-0002-6136-0136
Geu-Ru Hong 
https://orcid.org/0000-0003-4981-3304
In-Cheol Kim , MD, PhD1,2, Hyuk-Jae Chang , MD, PhD1, In-Jeong Cho, MD1 ,  
Chi Young Shim , MD, PhD1, Geu-Ru Hong , MD, PhD1, Ji Hoe Heo , MD, PhD3, 
Hyo Suk Nam , MD, PhD3, Young-Jin Kim , MD, PhD4,  
Byoung-Wook Choi , MD, PhD4, and Namsik Chung, MD, PhD1
1 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, 
Korea
2 Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University 
College of Medicine, Daegu, Korea
3Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
4Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Benefit of Four-Dimensional Computed 
Tomography Derived Ejection Fraction 
of the Left Atrial Appendage to 
Predict Thromboembolic Risk in the 
Patients with Valvular Heart Disease
Ji Hoe Heo 
https://orcid.org/0000-0001-9898-3321
Hyo Suk Nam 
https://orcid.org/0000-0002-4415-3995
Young-Jin Kim 
https://orcid.org/0000-0003-4126-016X
Byoung-Wook Choi 
https://orcid.org/0000-0002-8326-9675
Conflict of Interest
The authors have no financial conflicts of 
interest.
Author Contributions
Conceptualization: Chang HJ, Kim IC, Hong 
GR, Heo JH, Kim YJ, Choi BW, Chung N; Data 
curation: Chang HJ, Kim IC, Shim CY, Hong GR, 
Heo JH, Nam HS, Kim YJ; Formal analysis: Kim 
IC; Investigation: Kim IC, Shim CY, Hong GR, 
Heo JH, Nam HS, Kim YJ; Methodology: Chang 
HJ, Kim IC, Cho IJ; Project administration: 
Chang HJ, Kim IC, Cho IJ, Hong GR, Choi BW, 
Chung N; Resources: Chang HJ, Kim IC, Shim 
CY; Software: Kim IC; Supervision: Chang 
HJ, Hong GR, Choi BW, Chung N; Validation: 
Chang HJ, Kim IC; Visualization: Chang HJ, 
Kim IC, Kim YJ; Writing - original draft: Kim IC; 
Writing - review & editing: Chang HJ, Kim IC, 
Cho IJ, Shim CY, Hong GR, Heo JH, Nam HS, 
Chung N.
INTRODUCTION
Spontaneous echo contrast (SEC) and thrombus in left atrium (LA) as well as left atrial 
appendage (LAA) detected in transesophageal echocardiography (TEE) were well known 
risk factors for cardioembolic stroke. Previous report revealed that decreased LAA emptying 
velocity (<55 cm/s) is an important contributor of thrombus and SEC.1)
There has been increased use of 4-dimensional cardiac computed tomography (4DCT) for 
the evaluation of valve disease particularly before valve surgery or transcatheter aortic valve 
replacement (TAVR). In clinical field, 4DCT is utilized to evaluate native and prosthetic valve 
morphology and function, to measure ascending aorta, aortic root and aortic annulus related with 
TAVR procedure, and to evaluate subvalvular structures such as papillary muscles and chordae 
tendinae. In addition, volumetric data of cardiac chambers including LAA can be measured.2)3)
Patients with valve disease are at higher risk of thrombus formation before and after 
surgery.4)5) Thus, predicting thromboembolic risk and adopting tailored anticoagulation 
might be important to avoid catastrophic complications in patients undergoing valve surgery. 
The aim of this study was to investigate the role of 4DCT performed for the evaluation of 
valve disease before surgery to predict the risk of thrombus formation.
MATERIALS AND METHODS
Patient population and data acquisition
Between March 2010 to March 2015, patients who underwent 4DCT and TEE for cardiac valve 
evaluation before surgery in Yonsei Cardiovascular Hospital were screened. Inclusion criteria 
was patients who underwent 4DCT and TEE with LAA velocity measurement within 3 months 
with maintained normal sinus rhythm during both exams. Exclusion criteria were patients 
with atrial fibrillation (AF) or flutter rhythm during any of the exam, more than moderate 
mitral regurgitation, prosthetic valve or intracardiac devices which generate artifact. Among 
150 patients who were initially screened, 37 patients with prosthetic heart valve and 51 
patients with AF or atrial flutter rhythm were excluded. Finally, 62 patients were included for 
the analysis in the current study.
Transesophageal echocardiography image acquisition and analysis
Standard TEE views were acquired as per recommendations of the American Society of 
Echocardiography guidelines using 5 MHz multi-plane probe with commercially available 
scanners (GE Vivid E9; Vingmed Ultrasound, Horten, Norway, Philips IE33 system; Phillips 
Medical Systems, Andover, MA, USA).6) LAA was observed at best image between 45 to 
90° including 2-dimensional, color Doppler images and pulsed-wave Doppler. Fractional 
area change (FACTEE) was calculated by dividing maximum area of LAA from the difference 
between maximum and minimum area of LAA (Figure 1). Peak end-diastolic emptying 
velocity at LAA in TEE view (VeTEE) was the mean of 3 consecutive values by pulsed-wave 
Doppler at LAA ostium. SEC was defined as smoke-like swirling pattern observed in LA or 
LAA after adjustment of optimal gain setting.7)
Computed tomography image acquisition and analysis
Cardiac computed tomography (CT) scans were performed with a dual-source CT 
scanner (SOMATOM Definition Flash; Siemens Healthcare, Erlangen, Germany) or 
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a 64-slice multidetector computed tomography (MDCT) (SOMATOM Sensation 64; 
Siemens Medical Solution, Erlangen, Germany). They were performed with retrospective 
electrocardiographically gated data acquisition (0–90% phase). The indication of the 
retrospective gating was to evaluate valvular function as well as coronary patency and 
adjacent thoracic structures according to the clinician's discretion. Vitrea 6.4 version 
workstation (Vital Images Inc., Minnetonka, MN, USA) was used for reconstruction and 
analyzing volume. After selecting LAA orifice at the level of left circumflex artery, LAA was 
separated from LA, and volume was measured during 10 cycles. Ejection fraction of left atrial 
appendage in computed tomography (EFCT) was calculated by dividing maximum volume 
from the difference between maximum and minimum volume (Figure 1).
Statistical analysis
All analyses were conducted using SPSS version 23.0 (SPSS Inc., Chicago, IL, USA). 
Continuous variables were expressed as mean±standard deviation and were compared 
using the independent t-test and Pearson correlation coefficient. Variables which were not 
normally distributed were compared using the Mann-Whitney U test. Categorical variables 
were compared using the χ2 test or Fisher's exact test, as appropriate. A p value of <0.05 was 
considered statistically significant. The best cut-off value of EFCT to predict the presence of 
SEC or thrombus were measured using receiver operator characteristic curve. Correlation 
between the parameters were also estimated.
RESULTS
Baseline characteristics and transthoracic echocardiography results
Baseline characteristics are compared in SEC/thrombus (+) group and SEC/thrombus (−) 
group (Table 1). Baseline characteristics were not significantly different between the 2 groups. 
Transthoracic echocardiography results are shown in Table 2. Left atrial volume index was 
significantly higher in the SEC/thrombus (+) group when compared to SEC/thrombus (−) group.
Left atrial appendage parameter measurement by 4-dimensional cardiac 
computed tomography and transesophageal echocardiography
Volumetric assessment of EFCT and functional assessment of VeTEE were significantly lower 
in SEC/thrombus (+) group. However, 2-dimensional area assessment by FACTEE was not 
significantly different between 2 groups (Table 3).
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End systole End diastole End systole End diastole
EF measured by 4DCT FAC measured by TEE
100 × 22.42 17.8%
22.42−18.42 =
Area=7.7cm2 Area=6.7cm2
100 × 7.7 13.0%
7.7−6.7 =A B
Figure 1. Representative image showing measurement of EFCT (A) and FACTEE (B). 
BP = blood pressure; EF = ejection fraction; EFCT = ejection fraction of left atrial appendage in computed 
tomography; FAC = fractional area change; FACTEE = fractional area change in transesophageal echocardiography 
view; LAA, = left atrial appendage; TEE = transesophageal echocardiography; 4DCT = 4-dimensional cardiac 
computed tomography.
Correlation between parameters
Correlation between EFCT and FACTEE, EFCT and VeTEE were compared. There was no significant 
correlation between FACTEE and EFCT (r=−0.072, p=0.577). Nevertheless, there was significant 
correlation between VeTEE and EFCT (r=0.431, p<0.001) (Figure 2). Additional Bland-Altman 
plot also showed relationship between measurements of EFCT and FACTEE, and measurement 
of EFCT and VeTEE (Supplementary Figure 1).
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Table 1. Baseline characteristics
Total (n=62) SEC/thrombus (+) (n=27) SEC/thrombus (−) (n=35) p value
Age (years) 58.7±11.9 60.9±17.7 0.560
Male sex (%) 14 (51.9) 19 (54.3) 0.849
Systolic BP (mmHg) 122.9±14.0 116.6±15.7 0.110
Diastolic BP (mmHg) 69.9±12.2 71.4±9.5 0.592
Heart rate (bpm) 75.2±13.7 75.4±12.3 0.962
Smoking (%) 10 (37.0) 10 (28.5) 0.779
HTN (%) 10 (37.0) 21 (60.0) 0.073
DM (%) 1 (3.7) 4 (11.4) 0.376
Dyslipidemia (%) 6 (22.2) 6 (17.1) 0.616
CKD (%) 0 (0) 2 (5.7) 0.500
HF (%) 5 (18.5) 6 (17.1) 0.888
CAD (%) 0 (0) 1 (2.9) 1.000
PAD (%) 0 (0) 1 (2.9) 1.000
Old CVA (%) 1 (3.7) 3 (8.6) 0.626
Hb (mg/dL) 13.4±1.9 12.5±2.0 0.078
NT-ProBNP (pg/mL) 2,367.1±3,698.4 2,181.8±3,431.3 0.890
Aspirin (%) 2 (7.4) 2 (5.7) 1.000
Anticoagulation (%) 2 (7.4) 0 (0) 0.186
Total radiation dose (mSV) 760.2±354.3 800.8±524.0 0.734
BP = blood pressure; CAD = coronary artery disease; CKD = chronic kidney disease; CVA = cerebrovascular accident; DM = diabetes mellitus; Hb = hemoglobin; 
HF = heart failure; HTN = hypertension; NT-ProBNP = N-terminal-prohormone of brain natriuretic peptide; PAD = peripheral artery disease; SEC = spontaneous 
echo contrast.
Table 2. Transthoracic echocardiography results
Total (n=62) SEC/thrombus (+) (n=27) SEC/thrombus (−) (n=35) p value
EF (%) 60.7±11.6 61.9±11.7 0.687
LVEDD (mm) 56.6±10.8 51.8±10.6 0.090
LVESD (mm) 39.3±9.8 35.6±9.5 0.144
LAVI, mL/m2 63.1±30.3 40.1±21.5 0.001
E (m/s) 1.00±0.50 0.89±0.42 0.434
A (m/s) 0.71±0.47 0.78±0.42 0.663
DT (ms) 169.5±46.6 202.0±54.9 0.060
E/e′ 18.2±9.2 17.1±6.1 0.636
DT = deceleration time; EF = ejection fraction; LAVI = left atrial volume index; LVEDD = left ventricular end-diastolic dimension; LVESD = left ventricular end-
systolic dimension; SEC = spontaneous echo contrast.
Table 3. LAA parameters measured by 4DCT and TEE
Total (n=62) SEC/thrombus (+) (n=27) SEC/thrombus (−) (n=35) p value
CT measurement
LAA diastolic volume (mL) 17.4±7.0 18.7±8.3 0.502
LAA systolic volume (mL) 11.0±5.1 10.5±5.3 0.707
EFCT (%) 36.8±16.6 44.9±12.0 0.030
TEE measurement
VeTEE (cm/s) 40.3±15.6 61.5±19.2 <0.001
LAA diastolic area (cm2) 5.19±1.86 5.66±2.06 0.355
LAA systolic area (cm2) 3.15±1.66 3.29±1.34 0.719
FACTEE 40.9±11.0 41.0±7.8 0.951
CT = computed tomography; EFCT = ejection fraction of left atrial appendage in computed tomography; FACTEE = fractional area change in transesophageal 
echocardiography view; LAA, = left atrial appendage; SEC = spontaneous echo contrast; TEE = transesophageal echocardiography; VeTEE = emptying velocity at 
left atrial appendage in transesophageal echocardiography view; 4DCT = 4-dimensional cardiac computed tomography.
Best cut-off value of ejection fraction of left atrial appendage in computed 
tomography predicting thromboembolic risk
Best cut-off value of EFCT predicting presence of SEC/thrombus was 37.5% (area under the 
curve [AUC], 0.654; sensitivity, 0.824; specificity, 0.536; p=0.038), and predicting VeTEE <55 
cm/s was also 37.5% (AUC, 0.704; sensitivity, 0.917; specificity, 0.500; p=0.007) by receiver 
operating curve (Figure 3).
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Figure 2. Correlation graph of EFCT and FACTEE (A) and EFCT and VeTEE (B). 
EFCT = ejection fraction of left atrial appendage in computed tomography; FACTEE = fractional area change in transesophageal echocardiography view; LAA = left 
atrial appendage; VeTEE = emptying velocity at left atrial appendage in transesophageal echocardiography view.
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Figure 3. Receiver operator characteristics curve presenting best cut-off value of EFCT predicting SEC or thrombus (A) and VeTEE <55 cm/s (B). 
AUC = area under the curve; EF= ejection fraction; EFCT = ejection fraction of left atrial appendage in computed tomography; LAA = left atrial appendage; 
NPV = negative predicative value; PPV = positive predicative value; SEC = spontaneous echo contrast; VeTEE = emptying velocity at left atrial appendage in 
transesophageal echocardiography view.
DISCUSSION
The main findings of this study are as follows: 1) EFCT and VeTEE were significantly lower in 
SEC/thrombus (+) group. However, FACTEE showed no correlation in regards of the presence 
of SEC or thrombus. 2) VeTEE was also correlated with EFCT, but FACTEE showed no correlation 
with EFCT. 3) Best cut-off value of LAA EF by 4DCT predicting thromboembolic risk and LAA 
peak emptying velocity of <55 cm/s was 37.5%.
Cardiac CT is a useful alternative to TEE for the diagnosis of LAA thrombus. Comparing CT and 
TEE for the diagnosis of LAA thrombus, the overall sensitivity and specificity were 96% and 92% 
respectively. Negative predictive value was up to 99%.8)9) Previous studies have shown that MDCT 
can find potential cardiac sources of cardioembolic stroke including LAA/LA thrombus, aortic 
atheroma, circulatory stasis and PFO.10)11) However, previous studies with CT acquired delayed 
image to evaluate LAA thrombus which is not routinely performed in most laboratories.11) The 
benefit of the current method is that we can apply EFCT in all CT scan with retrospective protocol. 
Further benefit of EFCT in patients with AF or without valvular heart disease need to be investigated.
TEE has been a gold standard for the detection of cardioembolic source in stroke patients. 
However, there are several drawbacks to use TEE as a routine practice. First, it is a semi-
invasive procedure which produces patient discomfort.10) Patients with neurological 
dysfunction are more difficult to tolerate the discomfort during procedure. Second, TEE 
cannot detect extracardiac source of thrombus which is also an important source of embolic 
stroke.12) Lastly, the ability of TEE for the detection of cardioembolic source is highly 
dependent by the physician and post-processing is impossible.
TEE has a superiority for temporal resolution than CT, however it can only visualize cross-
sectional image of LAA with complex structure.13) Moreover, there is a possibility to measure 
different cross-section during systole and diastole due to the beating effect. Functional 
measurements are less affected by beating effect since flow measurement is similar among 
whole LAA chamber regardless of the measurement site. We consider the most accurate 
measurement of anatomical EFCT and it is closely related with functional parameters as well as 
thromboembolic risk.
In our study, LAA EF by 4DCT had benefit for the prediction of SEC or intracardiac thrombus. 
SEC and intracardiac thrombus are well known risk factors for cardioembolic stroke. It was also 
correlated with functional parameter of LAA by TEE (LAA emptying velocity <55 cm/s). Best 
cut-off value predicting SEC or thrombus and emptying velocity <55 cm/s was LAA EF <37.5%.
4DCT can provide useful information for the evaluation of a patient with embolic stroke. 
Its utility for detecting intracardiac thrombus, patent foramen ovale, aortic atheroma, 
and coronary artery disease was previously reported.10)12)14) By 4DCT, we can also acquire 
functional information which was previously provided only by TEE. Those parameters are 
frequently used for thromboembolic risk assessment.
The indication of TAVR has been expanded recently, and increasing number of patients are 
undergoing CT before surgery or procedures. In virtue of advancement in CT protocols, 
patients get less radiation and contrast. Although, TEE still stands for gold standard of 
evaluating thromboembolic risk, 4DCT might have an alternative role which provides 
excellent spatial resolution and additional functional information.
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This study is retrospective cross-sectional single center study with small number of patients 
which might inherit limitations.
Patients with normal sinus rhythm were only enrolled to fairly compare the ability of LAA EF 
by 4DCT and LAA FAC by TEE with correlation to thromboembolic risk in this retrospective 
design study. AF is an important source of thromboembolism, but thromboembolic risk still 
exists in the patients with normal sinus rhythm undergoing valve surgery or procedures. 
Future study including AF patients might be an interesting topic.
In the present study, we evaluated composite of SEC and thrombus as study endpoint and 
outcome data (e.g., embolic stroke or death) was not available. However, both dense SEC 
and thrombus are strong risk factors for future thromboembolism.15-18) They are also related 
with poor clinical outcome and further studies are needed to investigate whether EFCT is 
related with hard outcomes such as stroke or death. It is worth to mention that how many 
actual patients would suffer from true thromboembolic events and we are expecting further 
prospective design study with larger population to evaluate the role of 4DCT predicting actual 
thromboembolic event.
In conclusion, the patients who undergo 4DCT before surgical correction of valvular heart 
disease, LAA EF by volume analysis using 4DCT has additional benefit to evaluate future 
thromboembolic risk.
SUPPLEMENTARY MATERIAL
Supplementary Figure 1
Bland-Altman plot showing relationship between measurements of EFCT and FACTEE, and 
measurement of EFCT and VeTEE.
Click here to view
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